Biotech firm Amyris, Inc. (NASDAQ: AMRS) and ImmunityBio (NASDAQ: IBRX), a clinical-stage immunotherapy company, have concluded their joint...
AMYRIS AND IMMUNITYBIO COMPLETE JOINT VENTURE FOR NEXT GENERATION COVID-19 RNA VACCINE PR Newswire EMERYVILLE...
Amyris, Inc. (AMRS) engages in the provision of bioscience solutions. It offers its products to health and wellness, clean beauty, and flavor and...
Biotechnology and renewable chemical company Amyris, Inc. (NASDAQ: AMRS) recently revealed that the company has entered into a joint venture and...
AMYRIS AND MINERVA FOODS COMPLETE JOINT VENTURE AND LICENSE AGREEMENTS TO SCALE LOW CARBON PROTEIN PRODUCTION PLATFORM PR Newswire EMERYVILLE...
Amyris Consumer Brands Deliver Record Black Friday Week Consumer Sales Up More Than 120% From 2020 PR Newswire EMERYVILLE, Calif., Nov. 30, 2021...
Amyris To Present At The Evercore ISI 4th Annual HealthCONx Conference On December 1, 2021 PR...
Amyris To Host Call Regarding Recent Financing Activity PR Newswire EMERYVILLE, Calif., Nov. 18, 2021 EMERYVILLE, Calif., Nov. 18, 2021...
Amyris Closes Upsized Offering Of $690.0 Million Of 1.50% Convertible Senior Notes Due 2026 PR Newswire EMERYVILLE, Calif., Nov. 15, 2021...
AMYRIS, INC. NASDAQ false 0001365916 0001365916 2021-11-09 2021-11-09 UNITED STATES SECURITIES AND...
Amyris Prices $600.0 Million Of 1.50% Convertible Senior Notes Due 2026 PR Newswire EMERYVILLE, Calif., Nov...
Amyris To Offer $400.0 Million Of Convertible Senior Notes Due 2026 PR Newswire EMERYVILLE, Calif., Nov. 8, 2021 EMERYVILLE, Calif., Nov. 8, 2021...
000136591612/312021Q3FALSE311100013659162021-01-012021-09-30xbrli:shares00013659162021-11-03iso4217:USD00013659162021-09-3000013659162020-12-31...
Amyris, Inc. Reports Third Quarter 2021 Financial Results - Record underlying revenue and record consumer...
News
Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
